10h
News Medical on MSNChronic inflammation's connection to atrial fibrillation points to IL-1β as a promising treatment targetA recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and ...
Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2024 results conference call for investors and analysts.
12h
News Medical on MSNGranzyme K identified as key trigger of complement system in autoimmune diseasesOur immune system is armed with an array of defenses designed to detect and eliminate harmful threats. One of its most powerful defense mechanisms is the complement system-a group of proteins that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results